Mary Cushman: Association of Atrial Fibrillation with Risk of Incident Cognitive Impairment
Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Pleased to share my postdoc Vinh Le, MD’s first 1st author publication!
Now out in The American Journal of Cardiology! He reports the association of atrial fibrillation with risk of incident cognitive impairment in the 30,000-person REGARDS study!
Findings were somewhat surprising. AF was associated with ICI only in people with pre-baseline stroke, not otherwise. Inflammation biomarkers modestly attenuated this association, suggesting important links between cardiovascular and brain health.
Congratulations Dr. Le!”
Title: Atrial Fibrillation and Risk of Incident Cognitive Impairment: The Reasons for Geographic and Racial Differences in Stroke Study
Authors: Vinh H. Le, Katherine S. Wilkinson, Suzanne E. Judd, Elsayed Z. Soliman, Hyacinth I. Hyacinth, Melissa J. Smith, Nels C. Olson, Mary Cushman
Read the Full Article on The American Journal of Cardiology
Find more posts featuring Mary Cushman on Hemostasis Today.
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part
-
Mar 17, 2026, 17:26Danny Hsu: Navigating a Rebalanced Hemostatic State in Decompensated Cirrhosis
-
Mar 17, 2026, 17:21Matías J Alet on Acute Ischemic Stroke With Low NIHSS at NeuroQuality
-
Mar 17, 2026, 17:16S1PR4 Controls Platelet Fibrinogen Binding and Thrombus Formation – JTH
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs